医用大麻市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00015806
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 192
Buy Now

[研究报告]医用大麻市场规模预计将从2020年的89.266亿美元增长到2028年的491.164亿美元;预计 2021 年至 2028 年复合年增长率为 23.9%。

分析师观点:

医用大麻因其药用特性已被使用了几个世纪,现在正在获得认可并得到世界许多地方的认可。它通常由医疗保健专业人员开出或推荐,以帮助控制症状或改善患有特定病症的患者的生活质量。近年来,在接受度提高、法规变化和患者需求不断增长的推动下,医用大麻市场经历了大幅增长和转型。医用大麻产品有多种形式,以满足不同患者的喜好和医疗条件。这些包括花、油、胶囊食品、外用食品和浓缩物。公司正在投资产品创新、开发新配方、改进给药方法,以提高疗效、剂量控制和患者便利性。医用大麻被用来缓解症状和管理各种医疗状况。开具或推荐使用医用大麻的一些主要疾病包括慢性疼痛、多发性硬化症、癫痫、炎症性肠病以及化疗引起的恶心和呕吐。正在进行临床研究和试验,以提高医用大麻对各种病症的功效和安全性。科学进步有助于建立医疗保健专业人员和监管机构的信心,促进医用大麻市场的增长。此外,患者和医疗保健专业人员对大麻潜在医疗益处的认识和理解有所提高。了解大麻的治疗特性后,患者正在寻求替代治疗方案,并探索医用大麻作为其病情的潜在解决方案。因此,不断增长的患者需求是医用大麻市场的重要驱动力。

市场概述:

医用大麻是指使用大麻植物或其提取物来缓解症状或治疗某些疾病。大麻植物含有多种称为大麻素的化合物,它们与人体的内源性大麻素系统相互作用,产生各种治疗效果。医用大麻可以通过多种给药方式食用,包括吸烟、蒸发、摄入食物、使用酊剂、外用和服用胶囊。医用大麻市场潜在的经济机会吸引了大量投资并带动了该行业的增长。公司正在投资种植设施、研发、生产基础设施和分销网络,以满足医用大麻市场日益增长的需求。例如,2022 年 11 月,生物制药研究公司宣布完成 2000 万美元的 A 轮融资,使公司能够积极扩展业务、增加产品供应、开展赞助研究并执行其上市战略。此外,投资涌入促进了医用大麻市场的扩张和成熟。

战略见解

市场驱动因素:

医用大麻审批数量不断增加大麻产品推动医用大麻市场增长

大麻的药用潜力吸引了各种研究人员和公司在医疗应用中使用大麻。例如,四氢大麻酚(THC)主要用于生产医药产品。美国食品和药物管理局 (FDA) 已批准基于 THC 的药品,例如大麻隆 (Cesamet) 和屈大麻酚 (Marinol),用于治疗接受化疗的患者的恶心;这些药物还用于刺激患有消耗综合症的患者的食欲,消耗综合症是艾滋病的适应症之一。同样,各种基于大麻的产品已获得批准或正在进行临床试验。例如,nabiximols (Sativex) 是一种已批准的药物,已在加拿大、英国和一些欧洲国家商业化。 Nabiximols 是一种大麻提取物,用于治疗与多发性硬化症相关的痉挛和神经性疼痛。它由 THC 和其他大麻二酚 (CBD) 组合配制而成。 2020年2月,加拿大公司CanaQuest Medical Corp向加拿大卫生部申请批准Mentabinol的生产和商业化。 Mentabinol是一种以THC为基础的产品,其批准申请已根据《大麻法》提交。

除了接受西方国家的医用大麻产品并在亚洲市场商业化外,澳大利亚、新加坡等国家泰国、新西兰、韩国也已将大麻种植合法化。例如,2021年3月,新西兰卫生部和药用大麻管理局批准Tilray的药用大麻产品在全国范围内商业化。此外,该国也是澳大利亚医用大麻的主要供应国之一。 Tilray 的产品是在加拿大经过认证、符合良好生产规范 (GMP) 的工厂生产的。因此,医用大麻审批量的增加和公司业务的扩张正在推动预测期内医用大麻市场的增长。

细分分析:

根据产品类型,医用大麻大麻市场分为花、浓缩物、片剂、大麻油和外用药膏、胶囊、饮料和食品。 2019年,花卉领域可能占据医用大麻市场的最大份额。然而,由于与吸入方法相比,饮料和食品领域预计将在 2021 年至 2028 年期间实现医用大麻市场最高的复合年增长率。这对于需要全天持续症状管理的慢性病患者尤其有益。大麻花呈树脂状,其花蕾可通过提取活性大麻素加工成医药级药物。花顶可以制成各种产品,如酏剂、酊剂、药膏、膏剂、乳膏和其他制剂,用于治疗外部和内部疾病。

大麻花中存在的大麻素会影响神经系统,包括大脑和神经。这些药物可以通过处方以干花或标准化质量的提取物的形式获得。这些花在医用大麻市场中占有主要份额,因为大麻素含量最高的是大麻叶和花。因此,上述因素在预测期内正在推动医用大麻市场的皮肤护理领域的发展。

区域分析

北美医用大麻市场估值为美元2020年为622199万美元,预计到2028年将达到3481859万美元;预计在预测期内复合年增长率为 24.2%。北美医用大麻市场分为美国、加拿大和墨西哥。美国拥有北美最大的市场,由于公众对医用大麻的认识不断提高,探索创新治疗应用的研究和合作不断增加,医用大麻市场预计将增长。例如,2023 年 2 月,Bennabis Health 和 Canna Care Docs 联手为医用大麻患者提供负担得起、可靠的资源和安全获取。这种独特的合作使两个组织能够巩固其作为市场领导者的地位,并为医用大麻患者节省大量费用。此外,在医疗保健业务中采用数字工具来提高质量并同时降低成本也有助于促进美国和其他北美国家医用大麻的增长,这将推动医用大麻市场的增长。

主要参与者分析

医用大麻市场分析由 Aphria, Inc.、Aurora Cannabis、Cannabis Science, Inc.、Canopy Growth Corporation、Medical Marijuana, Inc. 等参与者组成, VIVO Cannabis Inc、Tikun Olam、Tilray、The Cronos Group、Canvory 等由于提供多样化的产品组合而成为排名前两位的参与者。

近期发展

无机和有机战略,例如由于医用大麻市场上的公司高度采用并购。下面列出了医用大麻市场最近的一些关键市场发展:

  • 2023年2月,Aurora Cannabis Inc.和MedReleaf Australia推出了CraftPlant,这是一个针对患者的新医用大麻品牌在澳大利亚市场。 CraftPlant 品牌包括三种供医生开处方的新产品 – Greendae、Navana 和 HiVolt。
  • 2021 年 4 月,Reddy's Laboratories 和 MediCane Health 在德国推出了医用大麻产品。作为 Dr. Reddy's 和 MediCane 于 2021 年开始合作的一部分,MediCane 将通过其位于葡萄牙的欧盟 GMP 认证工厂向 Dr. Reddy's 供应医用大麻产品,并提供物流和监管支持。
  • 在2021 年 5 月,Curaleaf Holdings, Inc. 在德国推出了一系列医用大麻产品。高 THC 油产品的首次推出旨在满足患者的即时需求,并将在一年内扩展,以油和花的形式纳入许多不同的强度和 THC/CBD 配方,以满足广泛的患者需求。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the cost of medical cannabis products?

The cost of medical cannabis varies according to the forms of medical cannabis. For instance, one gram of cannabis bud may cost ~ US$ 2-US$ 20 and may increase as per the quantity and dosages.

What are the driving factors for the medical cannabis market across the globe?

Key factors that are driving growth of the market are increasing number of approvals for medical cannabis products, rising acceptance for medicinal use of cannabis in developing countries, growing research on medicinal use of cannabis, and escalating government funding for spreading awareness and exploring medicinal benefits of cannabis. However, illegal use of cannabis as street drug and misconceptions regarding cannabis is a key factor restraining the market growth.

What is Medical Cannabis?

Cannabis belongs to the cannabaceae family. Cannabis is also known with other names such as grass, pot, hash, weed, reefer, dope, herb, mull, buddha, ganja, joint, stick, buckets, cones, skunk, hydro, yarndi, smoke and hooch. It is used for medical purposes for many years. Recent studies show that cannabis may be useful to help conditions such as nausea and vomiting, particularly when associated with chemotherapy, glaucoma, epilepsy, and asthma. Therefore, it is often called as medical cannabis.

The List of Companies - Medical Cannabis Market

  1. Aphria, Inc.
  2. Aurora Cannabis
  3. Cannabis Science, Inc.
  4. Canopy Growth Corporation
  5. Medical Marijuana, Inc.
  6. VIVO Cannabis Inc
  7. Tikun Olam
  8. Tilray
  9. The Cronos Group
  10. CANVORY

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports